• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

7995 例 SARS-CoV-2 感染患者的临床特征和结局。

Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.

机构信息

Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, United States of America.

Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America.

出版信息

PLoS One. 2021 Mar 31;16(3):e0243291. doi: 10.1371/journal.pone.0243291. eCollection 2021.

DOI:10.1371/journal.pone.0243291
PMID:33788846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8011821/
Abstract

OBJECTIVE

Severe acute respiratory syndrome virus (SARS-CoV-2) has infected millions of people worldwide. Our goal was to identify risk factors associated with admission and disease severity in patients with SARS-CoV-2.

DESIGN

This was an observational, retrospective study based on real-world data for 7,995 patients with SARS-CoV-2 from a clinical data repository.

SETTING

Yale New Haven Health (YNHH) is a five-hospital academic health system serving a diverse patient population with community and teaching facilities in both urban and suburban areas.

POPULATIONS

The study included adult patients who had SARS-CoV-2 testing at YNHH between March 1 and April 30, 2020.

MAIN OUTCOME AND PERFORMANCE MEASURES

Primary outcomes were admission and in-hospital mortality for patients with SARS-CoV-2 infection as determined by RT-PCR testing. We also assessed features associated with the need for respiratory support.

RESULTS

Of the 28605 patients tested for SARS-CoV-2, 7995 patients (27.9%) had an infection (median age 52.3 years) and 2154 (26.9%) of these had an associated admission (median age 66.2 years). Of admitted patients, 2152 (99.9%) had a discharge disposition at the end of the study period. Of these, 329 (15.3%) required invasive mechanical ventilation and 305 (14.2%) expired. Increased age and male sex were positively associated with admission and in-hospital mortality (median age 80.7 years), while comorbidities had a much weaker association with the risk of admission or mortality. Black race (OR 1.43, 95%CI 1.14-1.78) and Hispanic ethnicity (OR 1.81, 95%CI 1.50-2.18) were identified as risk factors for admission, but, among discharged patients, age-adjusted in-hospital mortality was not significantly different among racial and ethnic groups.

CONCLUSIONS

This observational study identified, among people testing positive for SARS-CoV-2 infection, older age and male sex as the most strongly associated risks for admission and in-hospital mortality in patients with SARS-CoV-2 infection. While minority racial and ethnic groups had increased burden of disease and risk of admission, age-adjusted in-hospital mortality for discharged patients was not significantly different among racial and ethnic groups. Ongoing studies will be needed to continue to evaluate these risks, particularly in the setting of evolving treatment guidelines.

摘要

目的

严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)已在全球范围内感染了数百万人。我们的目标是确定与 SARS-CoV-2 患者住院和疾病严重程度相关的危险因素。

设计

这是一项基于临床数据存储库的 7995 例 SARS-CoV-2 患者真实世界数据的观察性、回顾性研究。

设置

耶鲁纽黑文健康系统(YNHH)是一家拥有 5 家医院的学术医疗系统,为城市和郊区的社区和教学设施提供多样化的患者群体。

人群

本研究纳入了 2020 年 3 月 1 日至 4 月 30 日期间在 YNHH 进行 SARS-CoV-2 检测的成年患者。

主要结果和表现测量

主要结局是通过 RT-PCR 检测确定的 SARS-CoV-2 感染患者的住院和院内死亡率。我们还评估了与呼吸支持需求相关的特征。

结果

在接受 SARS-CoV-2 检测的 28605 例患者中,7995 例(27.9%)感染了 SARS-CoV-2(中位年龄 52.3 岁),其中 2154 例(26.9%)需要住院治疗(中位年龄 66.2 岁)。在住院患者中,2152 例(99.9%)在研究结束时出院。其中,329 例(15.3%)需要有创机械通气,305 例(14.2%)死亡。年龄增长和男性与住院和院内死亡率呈正相关(中位年龄 80.7 岁),而合并症与住院或死亡风险的相关性较弱。黑人(OR 1.43,95%CI 1.14-1.78)和西班牙裔(OR 1.81,95%CI 1.50-2.18)被确定为住院的危险因素,但在出院患者中,年龄调整后的院内死亡率在不同种族和族裔群体之间没有显著差异。

结论

本观察性研究确定,在 SARS-CoV-2 感染检测呈阳性的人群中,年龄较大和男性是 SARS-CoV-2 感染患者住院和院内死亡的最强相关风险因素。虽然少数族裔群体的疾病负担和住院风险较高,但出院患者的年龄调整后院内死亡率在不同种族和族裔群体之间没有显著差异。需要进行进一步的研究来继续评估这些风险,特别是在治疗指南不断演变的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dca/8011821/431362a3d9c9/pone.0243291.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dca/8011821/dad95fce87ba/pone.0243291.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dca/8011821/0d64e4ddaa2a/pone.0243291.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dca/8011821/9c3cf871fde2/pone.0243291.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dca/8011821/431362a3d9c9/pone.0243291.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dca/8011821/dad95fce87ba/pone.0243291.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dca/8011821/0d64e4ddaa2a/pone.0243291.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dca/8011821/9c3cf871fde2/pone.0243291.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dca/8011821/431362a3d9c9/pone.0243291.g004.jpg

相似文献

1
Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.7995 例 SARS-CoV-2 感染患者的临床特征和结局。
PLoS One. 2021 Mar 31;16(3):e0243291. doi: 10.1371/journal.pone.0243291. eCollection 2021.
2
Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection.7995例新型冠状病毒2型感染患者的临床特征及转归
medRxiv. 2020 Nov 8:2020.07.19.20157305. doi: 10.1101/2020.07.19.20157305.
3
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.与 SARS-CoV-2 谱系 B.1.1.7 相关的在英国的死亡率和重症监护病房入院率:一项观察性队列研究。
Lancet Infect Dis. 2021 Nov;21(11):1518-1528. doi: 10.1016/S1473-3099(21)00318-2. Epub 2021 Jun 23.
4
Racial Disparities in COVID-19 Testing and Outcomes : Retrospective Cohort Study in an Integrated Health System.COVID-19 检测和结果的种族差异:综合卫生系统中的回顾性队列研究。
Ann Intern Med. 2021 Jun;174(6):786-793. doi: 10.7326/M20-6979. Epub 2021 Feb 9.
5
Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.美国对 135794 名儿科患者进行严重急性呼吸综合征冠状病毒 2 检测的评估。
JAMA Pediatr. 2021 Feb 1;175(2):176-184. doi: 10.1001/jamapediatrics.2020.5052.
6
Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.纽约市一家城市医疗中心的 COVID-19 患者种族与合并症及生存率的关系。
JAMA Netw Open. 2020 Sep 1;3(9):e2019795. doi: 10.1001/jamanetworkopen.2020.19795.
7
Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.2020 年 2 月至 2021 年 3 月期间美国种族和农村地区与 SARS-CoV-2 感染、死亡率和病死率关联变化的研究:一项基于人群的队列研究。
PLoS Med. 2021 Oct 21;18(10):e1003807. doi: 10.1371/journal.pmed.1003807. eCollection 2021 Oct.
8
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.利用美国国家 COVID 队列协作的数据,对美国成年人中 SARS-CoV-2 感染的临床特征和临床严重程度进行临床描述和预测。
JAMA Netw Open. 2021 Jul 1;4(7):e2116901. doi: 10.1001/jamanetworkopen.2021.16901.
9
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
10
Racial and Ethnic Inequities in Cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2.新冠疫情期间,SARS-CoV-2 感染者的癌症诊疗连续性中的种族和民族差异
JAMA Netw Open. 2024 May 1;7(5):e2412050. doi: 10.1001/jamanetworkopen.2024.12050.

引用本文的文献

1
Differences in COVID-19-Related Hospitalization, Treatment, Complications, and Death by Race and Ethnicity and Area-Level Measures Among Individuals with Cancer in the ASCO Registry.美国临床肿瘤学会(ASCO)登记处中癌症患者因种族、民族及地区层面指标在与新冠病毒病(COVID-19)相关的住院治疗、并发症和死亡方面存在的差异。
Cancers (Basel). 2025 Mar 2;17(5):857. doi: 10.3390/cancers17050857.
2
Promoting Collaborative Scholarship During the COVID-19 Pandemic Through an Innovative COVID-19 Data Explorer and Repository at Yale School of Medicine: Development and Usability Study.在 COVID-19 大流行期间通过耶鲁医学院创新的 COVID-19 数据探索者和存储库促进协作奖学金:开发和可用性研究。
JMIR Form Res. 2024 Sep 3;8:e52120. doi: 10.2196/52120.
3

本文引用的文献

1
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study.COVID-19 患者 3894 例的常见心血管危险因素与住院死亡率:来自意大利多中心 CORIST 研究的生存分析和基于机器学习的发现。
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1899-1913. doi: 10.1016/j.numecd.2020.07.031. Epub 2020 Jul 31.
2
Racial, Economic, and Health Inequality and COVID-19 Infection in the United States.美国的种族、经济和健康不平等与 COVID-19 感染。
J Racial Ethn Health Disparities. 2021 Jun;8(3):732-742. doi: 10.1007/s40615-020-00833-4. Epub 2020 Sep 1.
3
Yin and yang of interferons: lessons from the coronavirus disease 2019 (COVID-19) pandemic.
干扰素的阴阳两面:来自 2019 冠状病毒病(COVID-19)大流行的教训。
Curr Opin Immunol. 2024 Apr;87:102423. doi: 10.1016/j.coi.2024.102423. Epub 2024 May 21.
4
Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2.慢性 HIV 感染对 SARS-CoV-2 急性免疫反应的影响。
J Acquir Immune Defic Syndr. 2024 May 1;96(1):92-100. doi: 10.1097/QAI.0000000000003399.
5
Vitamin D Levels as a Marker of Severe SARS-CoV-2 Infection.维生素D水平作为严重新型冠状病毒2型感染的一个标志物
Life (Basel). 2024 Jan 31;14(2):210. doi: 10.3390/life14020210.
6
Risk factors for SARS-CoV-2 related mortality and hospitalization before vaccination: A meta-analysis.接种疫苗前与SARS-CoV-2相关的死亡和住院的危险因素:一项荟萃分析。
PLOS Glob Public Health. 2022 Nov 2;2(11):e0001187. doi: 10.1371/journal.pgph.0001187. eCollection 2022.
7
The role of immune activation and antigen persistence in acute and long COVID.免疫激活和抗原持续存在在急性和长新冠中的作用。
J Investig Med. 2023 Jun;71(5):545-562. doi: 10.1177/10815589231158041. Epub 2023 Mar 6.
8
Case growth analysis to inform local response to COVID-19 epidemic in a diverse U.S community.基于病例增长分析,为美国多元化社区制定针对 COVID-19 疫情的当地应对策略。
Sci Rep. 2022 Oct 4;12(1):16217. doi: 10.1038/s41598-022-20502-2.
9
Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence.抗抑郁药物与2019冠状病毒病:基础与临床证据综述
J Clin Med. 2022 Jul 12;11(14):4038. doi: 10.3390/jcm11144038.
10
Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves.儿童 SARS-CoV-2 症状和 COVID-19 大流行期间合并感染率的差异。
J Clin Virol. 2022 Sep;154:105220. doi: 10.1016/j.jcv.2022.105220. Epub 2022 Jun 23.
Racial and Ethnic Disparities in Population-Level Covid-19 Mortality.
人群层面新冠病毒疾病(Covid-19)死亡率的种族和族裔差异。
J Gen Intern Med. 2020 Oct;35(10):3097-3099. doi: 10.1007/s11606-020-06081-w. Epub 2020 Aug 4.
4
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
5
Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes.导致疾病结果的对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)免疫反应中的性别差异。
medRxiv. 2020 Jun 26:2020.06.06.20123414. doi: 10.1101/2020.06.06.20123414.
6
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.在底特律市区的一系列患者中,与 2019 年冠状病毒病相关的临床特征和发病率。
JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270.
7
Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China.中国武汉新冠肺炎住院患者的临床特征及死亡风险因素
Clin Transl Med. 2020 Jun;10(2):e40. doi: 10.1002/ctm2.40. Epub 2020 Jun 4.
8
Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.高血压和降压治疗与 COVID-19 死亡率的关联:一项回顾性观察研究。
Eur Heart J. 2020 Jun 7;41(22):2058-2066. doi: 10.1093/eurheartj/ehaa433.
9
Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.衰老和呼吸道病毒感染免疫反应的作用:对 COVID-19 的潜在影响。
J Immunol. 2020 Jul 15;205(2):313-320. doi: 10.4049/jimmunol.2000380. Epub 2020 Jun 3.
10
Covid-19 related hospital admissions in the United States: needs and outcomes.美国与新冠病毒疾病相关的住院情况:需求与结果。
BMJ. 2020 May 27;369:m2082. doi: 10.1136/bmj.m2082.